Are there ways to address alternatives to the sharing requirement that meet CIRM’s goal of encouraging access to CIRM-Funded Research?
Yes. CIRM may approve alternatives if: • The financial burden becomes onerous; • The material or its transfer could pose a public health risk; • The request is otherwise inappropriate, as determined by the CIRM. In addition, in lieu of sharing, Grantee may provide requestor with the information necessary to reconstruct or obtain the material. With CIRM’s prior approval, the obligations to share cease when the materials are broadly commercially available. Finally, there is no obligation to share third party materials described in publications such as raw materials use to develop the published biomedical material, or materials covered by third party IP rights.
